1. Home
  2. SNY vs SIGIP Comparison

SNY vs SIGIP Comparison

Compare SNY & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SIGIP
  • Stock Information
  • Founded
  • SNY 1994
  • SIGIP N/A
  • Country
  • SNY France
  • SIGIP United States
  • Employees
  • SNY N/A
  • SIGIP 2800
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SIGIP Property-Casualty Insurers
  • Sector
  • SNY Health Care
  • SIGIP Finance
  • Exchange
  • SNY Nasdaq
  • SIGIP Nasdaq
  • Market Cap
  • SNY 116.5B
  • SIGIP N/A
  • IPO Year
  • SNY N/A
  • SIGIP N/A
  • Fundamental
  • Price
  • SNY $48.70
  • SIGIP N/A
  • Analyst Decision
  • SNY Buy
  • SIGIP
  • Analyst Count
  • SNY 2
  • SIGIP 0
  • Target Price
  • SNY $62.50
  • SIGIP N/A
  • AVG Volume (30 Days)
  • SNY 2.1M
  • SIGIP N/A
  • Earning Date
  • SNY 07-24-2025
  • SIGIP N/A
  • Dividend Yield
  • SNY 3.31%
  • SIGIP N/A
  • EPS Growth
  • SNY 39.56
  • SIGIP N/A
  • EPS
  • SNY 5.45
  • SIGIP N/A
  • Revenue
  • SNY $48,817,552,946.00
  • SIGIP N/A
  • Revenue This Year
  • SNY $3.39
  • SIGIP N/A
  • Revenue Next Year
  • SNY $7.05
  • SIGIP N/A
  • P/E Ratio
  • SNY $17.56
  • SIGIP N/A
  • Revenue Growth
  • SNY N/A
  • SIGIP N/A
  • 52 Week Low
  • SNY $45.80
  • SIGIP N/A
  • 52 Week High
  • SNY $60.12
  • SIGIP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.32
  • SIGIP 50.39
  • Support Level
  • SNY $47.64
  • SIGIP $16.61
  • Resistance Level
  • SNY $49.37
  • SIGIP $17.00
  • Average True Range (ATR)
  • SNY 0.68
  • SIGIP 0.13
  • MACD
  • SNY 0.14
  • SIGIP 0.03
  • Stochastic Oscillator
  • SNY 30.56
  • SIGIP 63.54

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.

Share on Social Networks: